Rita Balsano

460 total citations
20 papers, 192 citations indexed

About

Rita Balsano is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rita Balsano has authored 20 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Rita Balsano's work include Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Rita Balsano is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Rita Balsano collaborates with scholars based in Italy, Netherlands and United States. Rita Balsano's co-authors include Ingrid Garajová, Elisa Giovannetti, Chiara Tommasi, Luca Morelli, Andrea Cavazzoni, Annalisa Comandatore, Fabio Gelsomino, Godefridus J. Peters, Lorenza Rimassa and Valentina Zanuso and has published in prestigious journals such as Annals of Oncology, Current Pharmaceutical Design and Cells.

In The Last Decade

Rita Balsano

17 papers receiving 190 citations

Peers

Rita Balsano

ONCOL

PRM

IMMUN

Lucian Miron Romania

Taiying Lu China

Yuqing Miao China

Shimei Qiu China

Jun Wen China

Baohong Yang China

Verena Wagner Germany

Eva Hulstaert Belgium

Ryotaro Matsumoto Japan

Lucian Miron Romania

Rita Balsano

125 ×1.4

ONCOL

75 ×0.9

57 ×1.1

76 ×2.4

PRM

20 ×0.8

IMMUN

Citations per year, relative to Rita Balsano Rita Balsano (= 1×) peers Lucian Miron

Countries citing papers authored by Rita Balsano

Since Specialization

Citations

This map shows the geographic impact of Rita Balsano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Balsano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Balsano more than expected).

Fields of papers citing papers by Rita Balsano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Balsano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Balsano. The network helps show where Rita Balsano may publish in the future.

Co-authorship network of co-authors of Rita Balsano

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Balsano. A scholar is included among the top collaborators of Rita Balsano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Balsano. Rita Balsano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cammarota, Antonella, Rita Balsano, Tiziana Pressiani, et al.. (2025). The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies. Cancers. 17(2). 272–272. 1 indexed citations

Balsano, Rita, et al.. (2025). Combining VEGF and PD-1/PD-L1 inhibition in advanced hepatocellular carcinoma: clinical trials, real-world evidence, and future directions. Expert Opinion on Biological Therapy. 25(9). 989–1006.

Balsano, Rita, et al.. (2023). Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights. Current Oncology. 30(4). 3871–3885. 15 indexed citations

Niger, Monica, Federico Nichetti, Sabina Murgioni, et al.. (2023). SO-3 Clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer: Preliminary results from the multicenter B-REAL study. Annals of Oncology. 34. S162–S163. 1 indexed citations

Zanuso, Valentina, et al.. (2023). Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1689–1708. 4 indexed citations

Gelsomino, Fabio, Rita Balsano, Stefania De Lorenzo, & Ingrid Garajová. (2022). Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Current Oncology. 29(2). 1223–1236. 6 indexed citations

Garajová, Ingrid, Andrea Cavazzoni, Roberta Minari, et al.. (2022). It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer. Life. 12(7). 960–960. 2 indexed citations

Garajová, Ingrid, Rita Balsano, Fabio Gelsomino, & Francesco Leonardi. (2022). Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?. Tumori Journal. 108(6). NP30–NP33. 1 indexed citations

Garajová, Ingrid, Rita Balsano, Fabio Gelsomino, et al.. (2022). Should patients on levothyroxine therapy be screened for pancreatic cancer?. PubMed. 93(6). e2022268–e2022268.

10.

Tommasi, Chiara, Rita Balsano, Benedetta Pellegrino, et al.. (2022). Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm?. Journal of Clinical Medicine. 11(23). 7239–7239. 25 indexed citations

11.

Balsano, Rita, Annalisa Comandatore, Andrea Cavazzoni, et al.. (2022). Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics. Cells. 11(17). 2671–2671. 21 indexed citations

12.

Comandatore, Annalisa, Rita Balsano, Mjriam Capula, et al.. (2022). Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. Diagnostics. 12(2). 286–286. 26 indexed citations

13.

Garajová, Ingrid, Giulia Rovesti, Rita Balsano, et al.. (2021). The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review. Pharmaceuticals. 14(1). 43–43. 9 indexed citations

14.

Pietri, Elisabetta, Rita Balsano, Fabio Gelsomino, et al.. (2021). The implication of liquid biopsies to predict chemoresistance in pancreatic cancer. Cancer Drug Resistance. 4(3). 559–572. 4 indexed citations

15.

Digiacomo, Graziana, Francesco Volta, Ingrid Garajová, Rita Balsano, & Andrea Cavazzoni. (2021). Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC. Life. 11(8). 843–843. 17 indexed citations

16.

Garajová, Ingrid, Rita Balsano, Chiara Tommasi, et al.. (2020). P-368 Primary tumor location in synchronous and metachronous liver metastases: Impact on patterns of recurrence and survival after hepatic resection. Annals of Oncology. 31. S209–S209.

17.

Garajová, Ingrid, Rita Balsano, Heling Wang, et al.. (2020). The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Review of Anticancer Therapy. 21(2). 165–176. 27 indexed citations

18.

Garajová, Ingrid, Rita Balsano, Chiara Tommasi, et al.. (2020). Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection.. PubMed. 92(1). e2021061–e2021061. 8 indexed citations

19.

Balsano, Rita, Chiara Tommasi, & Ingrid Garajová. (2019). State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?. Anticancer Research. 39(7). 3405–3412. 22 indexed citations

20.

Garajová, Ingrid, Rita Balsano, Chiara Tommasi, & Elisa Giovannetti. (2019). Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer. Current Pharmaceutical Design. 24(39). 4601–4604. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact